Diagnostic application in streptozotocin-induced diabetic retinopathy rats: A study based on Raman spectroscopy and machine learning.

Journal: Journal of biophotonics
PMID:

Abstract

Vision impairment caused by diabetic retinopathy (DR) is often irreversible, making early-stage diagnosis imperative. Raman spectroscopy emerges as a powerful tool, capable of providing molecular fingerprints of tissues. This study employs RS to detect ex vivo retinal tissue from diabetic rats at various stages of the disease. Transmission electron microscopy was utilized to reveal the ultrastructural changes in retinal tissue. Following spectral preprocessing of the acquired data, the random forest and orthogonal partial least squares-discriminant analysis algorithms were employed for spectral data analysis. The entirety of Raman spectra and all annotated bands accurately and distinctly differentiate all animal groups, and can identify significant molecules from the spectral data. Bands at 524, 1335, 543, and 435 cm were found to be associated with the preproliferative phase of DR. Bands at 1045 and 1335 cm were found to be associated with early stages of DR.

Authors

  • Kunhong Xiao
    Department of Optometry, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, China.
  • Li Li
    Department of Gastric Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
  • Yang Chen
    Orthopedics Department of the First Affiliated Hospital of Tsinghua University, Beijing, China.
  • Rong Lin
    College of Ocean Food and Biological Engineering, Jimei University, Xiamen, Fujian 361021, China.
  • Boyuan Wen
    Department of Ophthalmology and Optometry, Fujian Medical University, Fuzhou, Fujian Province, China.
  • ZhiQiang Wang
    The Affiliated Mental Health Center of Jiangnan University, Wuxi Mental Health Center, Wuxi 214151, Jiangsu, China.
  • Yan Huang
    Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX.